Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
GraysonAshby, M.D.
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Residents describe their training experience at Mayo Clinic's Department of Ophthalmology
Recent Videos
00:10:00
Star Diamond Corp Eyes Production: Largest Undeveloped Diamond Project Nears Key Milestones|Ewan Mason,CEO,Star Diamond Corp
00:10:00
Phantom Resources: Advancing High-Potential Gold Discoveries in Nevada with Expert Leadership|Paul Cowley,CEO,Phenom Resources
00:10:00
West Red Lake Gold Mines Gears Up for Gold Production at Madsen Mine|Gwen Preston,Vice President, Communications,West Red Lake Gold Mines Ltd
00:10:00
StrikePoint Gold Gears Up for Drilling at Hercules Project in Nevada|Michael G. Allen,CEO,StrikePoint Gold Inc
00:10:00
Randy Smallwood’s Contributions to Precious Metals and Industry Leadership | Randy Smallwood, CEO , Wheaton Precious Metal.
00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
Suggestions
00:10:00
Energy Market Differences and Future Trends | Pat Vincent-Collawn, CEO , PNM Resources Inc.
00:10:00
VerticalScope focused on building longterm shareholder value|COO, VerticalScope Holdings Inc
00:10:00
The Secret to Citadel's Success | Mark McConnell, CEO, Citadel Group Ltd CGL:ASX
00:10:00
Jonathan Thomas on Market Volatility, Investment Strategies, and Philanthropy | Jonathan Thomas, CEO , American Century Investments.
00:10:00
PCSgrades features an expert interview with Nikhil Sudan, President of Victory Capital InVest, offering insights into Victory Capital and investment research.
00:10:00
Unlocking the Power of ESG and SRI: Ethical Investing with AIO Financial | Bill Holliday - Certified Financial Planner (CFP) of AIO Financial, LLC
00:10:00
Carson Block, founder of Muddy Waters Research, joins 'Closing Bell' to explain why his firm began investigating Hannon Armstrong.
00:10:00
Concurrent Technologies (AIM) CEO Miles Adcock presents at the Cenkos Securities PLC (AIM) Virtual Growth & Innovation Forum.| Miles John Adcock occupies the position of Chief Executive Officer & Executive Director at Concurrent Technologies Plc.
00:10:00
curiosity to understand the changing world around us|Steve Kraus,Partner,Bessemer Venture Partners
00:10:00
Tailwind is focused on control investments in high quality, middle market companies|Caroline Adams,Vp,Tailwind Management LP
00:10:00
Presentation by the CEO of a Namibian Gold Exploration Company
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.